Description
Recombinant monoclonal antibody to CD21. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma THB-5. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.
Target
CD21
Target Alias Names
CR2, Complement receptor type 2, complement C3d receptor, C3dR, C3DR, Epstein-Barr virus receptor, EBV receptor, cluster of differentiation 21, THB 5
Isotype/Mimetic
IgG4-S228P
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression